Agree certainly the timing of revenue generation has been clearly far to optimistic, also there has always been a cloud over the % of expenses is for R&D uses. The underlying business is relatively strong and there is no risk of a CR, which is great, but the inability for the company to show scalability is of concern...
Covid has impacted 8CO very hard, it would be good to get some clear and candid feedback on the impact of project roll-out / execution in light of Covid, as this impact seems to an outside to be extreme.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.930M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 144858 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 154500 | 1 |
View Market Depth
| Last trade - 09.59am 07/08/2025 (20 minute delay) ? |
| 8CO (ASX) Chart |
Day chart unavailable